Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Samira ShaikhlyChief People Officer | Open-market sale10b5-1 plan | 06/29 | 06/30 | 2,178 sh | $35.18 | $76,622.04 | −73.3% | |
| Open-market sale10b5-1 plan | 06/22 | 06/24 | 15,000 sh2 trades | $35.51avg. | $532,590 | −13.5% | ||
Samira ShaikhlyChief People Officer | Open-market sale10b5-1 plan | 06/12 | 06/16 | 6,250 sh | $35.08 | $219,250 | −88.7% | |
| Open-market sale10b5-1 plan | 06/01 | 06/03 | 5,935 sh3 trades | $28.92avg. | $171,665.08 | −88.2% | ||
Samira ShaikhlyChief People Officer | Open-market sale10b5-1 plan | 05/26 | 05/28 | 11,798 sh | $30.06 | $354,647.88 | −93.7% | |
| Open-market sale10b5-1 plan | 04/15 | 04/17 | 4,000 sh3 trades | $24.34avg. | $97,354.08 | −2.2% | ||
| Open-market sale10b5-1 plan | 03/02 | 03/04 | 70,453 sh2 trades | $28.10avg. | $1,979,970.72 | −98.9% | ||
| Open-market sale10b5-1 plan | 02/18 | 02/20 | 4,000 sh2 trades | $28.96avg. | $115,856 | −2.2% | ||
Daniel D. LongSVP, Drug Discovery | Open-market sale | 25/11/10 | 25/11/13 | 3,501 sh | $18.06 | $63,228.06 | −3.6% | |
Alan EzekowitzDirector | Open-market buy | 25/03/07 | 25/03/10 | 13,319 sh | $6.93 | $92,300.67 | +12.8% | |
| Open-market buy | 25/03/04–25/03/06 | 25/03/06 | 86,681 sh3 trades | $5.95avg. | $515,897.55 | +497.6% | ||
| Open-market buy | 25/02/25–25/02/27 | 25/02/27 | 10,000 sh2 trades | $5.69avg. | $56,866.68 | +33.3% | ||
| Open-market buy | 25/02/25–25/02/27 | 25/02/27 | 17,000 sh3 trades | $5.71avg. | $97,000 | +2.3% | ||
Third Rock Ventures V10% Owner | Open-market buy | 25/02/24 | 25/02/26 | 18,861 sh | $6.00 | $113,166 | +0.4% | |
| Open-market buy | 25/02/20–25/02/21 | 25/02/24 | 1,040,342 sh2 trades | $5.93avg. | $6,167,378 | +33.0% | ||
| Open-market buy | 25/02/19–25/02/21 | 25/02/21 | 30,000 sh3 trades | $5.75avg. | $172,365 | No record | ||
| Open-market buy | 24/10/28 | 24/10/30 | 4,170,000 sh2 trades | $18.00avg. | $75,060,000 | No record | ||
| Open-market buy | 24/10/28 | 24/10/28 | 650,000 sh2 trades | $18.00avg. | $11,700,000 | No record |